Afya Posts 6.1% Q3 Revenue Growth, Reaffirms 2026 Guidance Ahead of Yduqs Merger
AFYA is trading near its 52-week low of $9.66 (6.9% above the low).
Summary
Afya grew Q3 revenue 6.1% to R$985.2 million and Adjusted EBITDA 8.7% to R$433.8 million, reaffirming 2026 guidance while net debt fell to R$1,199.8 million (~0.7x EBITDA) ahead of the pending Yduqs merger.
Key Events · Earnings and Guidance · AFYA
-
Q3 Revenue Up 6.1% YoY
Revenue reached R$985.2 million in 3Q26 versus R$928.5 million a year earlier, with 9M26 revenue up 6.7% to R$2,970.0 million (6.4% organic).
-
EBITDA Margin Expands 100 bps
3Q26 Adjusted EBITDA rose 8.7% to R$433.8 million at a 44.0% margin; 9M26 Adjusted EBITDA was R$1,351.8 million, up 4.6%, with margin down 90 bps to 45.5% on investment in Continuing Education and Medical Practice Solutions.
-
2026 Guidance Reaffirmed
Full-year 2026 outlook held at revenue of R$3,950-4,100 million, Adjusted EBITDA of R$1,700-1,800 million and capex of R$340-380 million.
-
Net Debt Falls to 0.7x EBITDA
Net debt excluding IFRS 16 fell R$169.7 million from December 31, 2025 to R$1,199.8 million, roughly 0.7x mid-guidance Adjusted EBITDA, after returning R$459.3 million to shareholders via dividends and buybacks.
Analysis · AFYA · Trade & Services
Steady third-quarter growth puts Afya on track for its full-year targets: revenue rose 6.1% to R$985.2 million and Adjusted EBITDA climbed 8.7% to R$433.8 million, with margin expanding 100 bps to 44.0%. Management reaffirmed 2026 guidance of R$3,950-4,100 million in revenue and R$1,700-1,800 million in Adjusted EBITDA. The nine-month picture is softer on margin (45.5%, down 90 bps) as Continuing Education and Medical Practice Solutions absorb investment spending, but cash generation is strong at a 99.5% conversion ratio and net debt fell R$169.7 million to R$1,199.8 million, about 0.7x mid-guidance EBITDA. These results land while the company is being absorbed into Yduqs under the September 23 merger agreement (69%/31% split, 6.408347 exchange ratio), so they mainly serve as the last standalone operating benchmark before shareholder and antitrust approvals.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AFYA was trading at $10.33 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $944.7M. The 52-week trading range was $9.66 to $16.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.